Table of Contents

company-logo

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FibroGen Dividend Announcement

• FibroGen does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on FibroGen dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

FibroGen Dividend History

FibroGen Dividend Yield

FibroGen current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing FibroGen stock? Use our calculator to estimate your expected dividend yield:

FibroGen Financial Ratios

P/E ratio-0.32
PEG ratio-0.06
P/B ratio-0.19
ROE56.23%
Payout ratio-1.85%
Current ratio1.28
Quick ratio1.16
Cash Ratio0.69

FibroGen Dividend FAQ

Does FibroGen stock pay dividends?
FibroGen does not currently pay dividends to its shareholders.
Has FibroGen ever paid a dividend?
No, FibroGen has no a history of paying dividends to its shareholders. FibroGen is not known for its dividend payments.
Why doesn't FibroGen pay dividends?
There are several potential reasons why FibroGen would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will FibroGen ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While FibroGen has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is FibroGen a dividend aristocrat?
FibroGen is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is FibroGen a dividend king?
FibroGen is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is FibroGen a dividend stock?
No, FibroGen is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy FibroGen stocks?
To buy FibroGen you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy FibroGen stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.